Schonfeld Strategic Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,896
| Closed | -$167K | – | 1846 |
|
|
2024
Q2 | $167K | Buy |
+14,896
| New | +$167K | ﹤0.01% | 1697 |
|
|
2023
Q3 | – | Sell |
-28,835
| Closed | -$106K | – | 1581 |
|
|
2023
Q2 | $106K | Sell |
28,835
-77,513
| -73% | -$286K | ﹤0.01% | 1629 |
|
|
2023
Q1 | $352K | Sell |
106,348
-255,765
| -71% | -$847K | ﹤0.01% | 1280 |
|
|
2022
Q4 | $1.4M | Sell |
362,113
-476,353
| -57% | -$1.85M | 0.01% | 976 |
|
|
2022
Q3 | $2.04M | Sell |
838,466
-220,175
| -21% | -$535K | 0.02% | 844 |
|
|
2022
Q2 | $2.1M | Sell |
1,058,641
-181,015
| -15% | -$358K | 0.02% | 678 |
|
|
2022
Q1 | $2.27M | Buy |
1,239,656
+558,972
| +82% | +$1.02M | 0.02% | 637 |
|
|
2021
Q4 | $960K | Buy |
680,684
+604,684
| +796% | +$853K | 0.01% | 905 |
|
|
2021
Q3 | $86K | Sell |
76,000
-365,873
| -83% | -$414K | ﹤0.01% | 1872 |
|
|
2021
Q2 | $707K | Sell |
441,873
-250,414
| -36% | -$401K | 0.01% | 1002 |
|
|
2021
Q1 | $1.22M | Buy |
692,287
+118,714
| +21% | +$209K | 0.01% | 786 |
|
|
2020
Q4 | $1.12M | Sell |
573,573
-158,150
| -22% | -$308K | 0.02% | 735 |
|
|
2020
Q3 | $1.75M | Buy |
731,723
+144,806
| +25% | +$346K | 0.03% | 505 |
|
|
2020
Q2 | $1.72M | Sell |
586,917
-136,510
| -19% | -$400K | 0.04% | 416 |
|
|
2020
Q1 | $2.08M | Sell |
723,427
-517,366
| -42% | -$1.49M | 0.13% | 191 |
|
|
2019
Q4 | $4.96M | Sell |
1,240,793
-329,615
| -21% | -$1.32M | 0.12% | 199 |
|
|
2019
Q3 | $6.99M | Sell |
1,570,408
-595,992
| -28% | -$2.65M | 0.21% | 133 |
|
|
2019
Q2 | $8.38M | Buy |
2,166,400
+1,941,400
| +863% | +$7.51M | 0.3% | 84 |
|
|
2019
Q1 | $853K | Buy |
+225,000
| New | +$853K | 0.03% | 545 |
|